Scientific Sessions
Scientific Sessions
  • Program
  • #AHA24
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA24
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 13th, 2020

New, simpler test may better detect salt sensitivity


Getty Images 1262616145

A new test to determine salt sensitivity will make it easier to identify people who are at risk for cardiovascular disease, said a co-moderator in Sunday’s “Salt-Sensitive Hypertension: What Is New?” session.

“Being salt sensitive causes a person to be approximately 60% more likely to  die from cardiovascular disease at a younger age, so being able to assess one’s Personal Salt Index (daily safe salt intake) is a promising advancement to decrease mortality from cardiovascular disease,” said Robin A. Felder, PhD, co-moderator of the session at 10:30-11:30 a.m. CST.

Traditional testing for salt sensitivity is expensive and tedious, said Dr. Felder, professor of pathology and associate director of clinical chemistry and toxicology at the University of Virginia School of Medicine in Charlottesville. It involves placing a patient on a highly controlled salt diet for two weeks with frequent measurements of blood pressure and testing renal function.

The new test, which examines the function of living renal cells excreted in the urine, can be performed on a single urine specimen. Currently, prospective studies are funded by the National Heart, Lung, and Blood Institute.

“If those prospective studies look promising, we hope to be able to apply this evidence for use with  patients in our university clinics,” said Dr. Felder, who will co-moderate the session with Kathryn L. Sandberg, PhD, professor and vice chair for research in the Department of Medicine at Georgetown University in Washington, D.C. “

Widespread testing is especially critical for people who may be salt sensitive — but are not hypertensive and not aware of their increased risk for cardiovascular disease.

As an estimate “Eighteen percent of Americans with normal blood pressure may be  salt sensitive,” Dr. Felder said. “Once one knows their Personal Salt Index  while having a normal blood pressure, then hypertensive medications may be unnecessary, unless they are both salt sensitive and become hypertensive.”

Making patients aware of their Personal Salt Index  could be an important primary preventative measure to  significantly impact decreasing  cardiovascular disease and increasing  the possibility of a longer, healthier life..

“A little appreciated group of salt-sensitive individuals are inverse salt sensitive,” Dr. Felder said. “Approximately 15% of Americans are inverse salt sensitive and appear to have essential hypertension  because low-salt diets actually raise their blood pressure.” 

The ability to identify inverse salt sensitivity  may reduce the likelihood that medications for lowering blood pressure are prescribed for those who should instead consume increasing amounts of daily salt until their blood pressure is within recommended guidelines

 “All Americans may one day  know their degree of salt sensitivity so they can consume the daily amount that would reduce or eliminate the chance of salt induced cardiovascular disease,” he said.

 


Interesting Stories
Unmet Needs in Hypertension Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
Lp(a) and Peripheral Artery Disease Toolkit
Sponsored by Kaneka Corporation
Lp(a) and Peripheral Artery Disease Toolkit
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Sponsored by Medscape
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Screening for Kidney Disease to Reduce CVD Risk
Sponsored by Bayer
Screening for Kidney Disease to Reduce CVD Risk
More Content
Health Tech winners
AHA24
AI medical company wins global health tech competition at #AHA24
Nov 20th, 2024
241116 American Heart Association Keynote 0080
AHA24
LBS 08: Advances in lipid therapeutics
Nov 20th, 2024
Crowd shot
AHA24
LBS 07: New approaches to managing AFib
Nov 20th, 2024
Stage shot
AHA24
LBS 06: Medical therapy for heart failure
Nov 20th, 2024
Stage shot
AHA24
LBS 05: Innovation in prevention
Nov 20th, 2024
French Quarter balcony shot
AHA24
Save the date for #AHA25 in New Orleans
Nov 20th, 2024
Asgar headshot
AHA24
Managing patients with symptomatic mitral or tricuspid regurgitation
Nov 18th, 2024
Nancy Brown headshot
AHA24
AHA CEO: Driving breakthroughs
Nov 18th, 2024
Shot of speakers
AHA24
Environmental crises call for more CV research
Nov 18th, 2024
Aha24 Nejm Web Image
AHA24
Streamlining the pathway to publish cardiovascular research
Nov 18th, 2024
Casadei headshot
AHA24
Dissecting the complex relationship between atrial cardiomyopathy and stroke
Nov 18th, 2024
Stage shot
AHA24
LBS 04: Coronary and valvular heart disease
Nov 18th, 2024